Literature DB >> 22832328

Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.

Junjeong Choi1, Woo-Hee Jung, Ja Seung Koo.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the expression of metabolism-related proteins such as Glut-1 and carbonic anhydrase IX (CAIX) according to breast cancer molecular subtype.
METHODS: We generated a tissue microarray of 276 breast cancer patients and performed immunohistochemical staining for known metabolism-related proteins, which were evaluated according to the molecular subtype.
RESULTS: The expression of IGF-1, MIF, and HIF-1α was correlated with the HER-2 type (p < 0.05). Glut-1 overexpression and CAIX expression were associated with TNBC type, especially with basal-like type, high histologic grade, estrogen receptor negativity, and progesterone receptor negativity (p < 0.05). The expression of Glut-1 and CAIX was correlated with statistical significance (p < 0.001).
CONCLUSION: We identified different patterns of expression of metabolism-related proteins according to the molecular subtypes of breast cancer defined by surrogate immunohistochemistry. Increased expression of HIF-1α, IGF-1, and MIF was noted in HER-2 type breast cancer and increased expression of Glut-1 and CAIX was noted in TNBC type breast cancer, especially in the basal-like subtype, which exhibited a glycolytic and acid-resistant tumor phenotype.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832328     DOI: 10.1159/000339513

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  44 in total

1.  Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status.

Authors:  Songmi Noh; Ji-Ye Kim; Ja Seung Koo
Journal:  Tumour Biol       Date:  2014-05-22

Review 2.  Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Authors:  Ales Vicha; David Taieb; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2014-05-08       Impact factor: 5.678

Review 3.  Breast Cancer Metabolism.

Authors:  Jessica Tan; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

4.  Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.

Authors:  Shari Pilon-Thomas; Krithika N Kodumudi; Asmaa E El-Kenawi; Shonagh Russell; Amy M Weber; Kimberly Luddy; Mehdi Damaghi; Jonathan W Wojtkowiak; James J Mulé; Arig Ibrahim-Hashim; Robert J Gillies
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

5.  Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues.

Authors:  Songmi Noh; Do Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2014-01-05

Review 6.  Targeting metabolism in breast cancer: How far we can go?

Authors:  Jing-Pei Long; Xiao-Na Li; Feng Zhang
Journal:  World J Clin Oncol       Date:  2016-02-10

7.  Metabolic phenotypes in triple-negative breast cancer.

Authors:  Sewha Kim; Do Hee Kim; Woo-Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2013-02-27

8.  Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Authors:  Yoon Jin Cha; Yon Hee Kim; Nam Hoon Cho; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer.

Authors:  Min-Sun Jin; Hyebin Lee; In Ae Park; Yul Ri Chung; Seock-Ah Im; Kyung-Hun Lee; Hyeong-Gon Moon; Wonshik Han; Kyubo Kim; Tae-Yong Kim; Dong-Young Noh; Han Suk Ryu
Journal:  Virchows Arch       Date:  2016-05-16       Impact factor: 4.064

10.  Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Authors:  Yon Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.